Medscape

Medscape InDiscussion: Myelofibrosis

Science EN ↓ Epizody: 12

Listen to Medscape InDiscussion: Myelofibrosis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999593. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Určitě navštivte web podcastu a podpořte jeho tvůrce: www.medscape.com

Autor

Medscape

Kategorie

Science

Web podcastu

www.medscape.com

Nejnovější epizoda

10. čvc 2025

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Nainstaluj zdarma Android téměř 10 mil. stažení · hodnocení 4,8 iOS už brzy

Epizody

S2 Episode 6: A Futuristic Vision for Treating Myelofibrosis 10.07.2025 30:09

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier interventions, and smarter diagnostics. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002058. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only...

S2 Episode 5: Posttransplant Monitoring in Myelofibrosis 10.06.2025 23:22

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and patient-centered transplant decisions in myelofibrosis care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002057. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast i...

S2 Episode 4: JAK Inhibitors: Too Many Choices or Not Enough? 08.05.2025 27:25

Join Drs Tania Jain and Prithviraj Bose as they discuss the available JAK inhibitors and how they use them to treat myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002056. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professi...

S2 Episode 3: Can We Prevent Myelofibrosis? The New Interferon Era 08.04.2025 23:22

Join Drs Tania Jain and Brandi Reeves as they discuss primary myelofibrosis and post-ET (essential thrombocythemia) and post-PV (polycythemia vera) myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002055. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended...

S2 Episode 2: Diet, Exercise, and Myelofibrosis: A Holistic Approach 06.03.2025 25:36

Join Drs Tania Jain and Krisstina Gowin as they discuss the role integrative medicine plays in the treatment of myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002054. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professional...

S2 Episode 1: What's Next? Clinical Trials in Myelofibrosis 06.03.2025 21:59

Drs Tania Jain and Ruben Mesa discuss the clinical trials and the future of myelofibrosis research. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002053. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Myeloprolifera...

S1 Episode 6: What Does the Future Look Like for Myelofibrosis? 06.11.2024 21:54

Join Drs Tania Jain and Gabriela Hobbs as they discuss their views on the future of research and patient care in myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999598. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professional...

S1 Episode 5: Transplant Tips, Talks, and Timing for Myelofibrosis 03.10.2024 26:37

Join Drs Tania Jain and Jeanne Palmer as they discuss their approach to transplant in myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999597. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Myelofibrosis...

S1 Episode 4: Myelofibrosis: Considering TP53 and Post-MPN AML 05.09.2024 21:55

Join Drs Tania Jain and Raajit Rampal as they discuss TP53, post-MPN AML, and high-risk MPNs in the context of myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999596. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals....

S1 Episode 3: What's Your Approach? Treating Myelofibrosis 07.08.2024 22:26

Join Drs Tania Jain and Lindsay Rein as they discuss the current treatment landscape and their approach to treating patients with myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999595. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US health...

S1 Episode 2: What's Next? Promising Trials and Therapeutics in Myelofibrosis 03.07.2024 25:24

Join Drs Tania Jain and Aaron Gerds as they discuss the latest developments in clinical trials and investigational therapeutics for MPNs. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999594. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare pr...

S1 Episode 1: Risk Stratification in Myelofibrosis: Which Model Should You Use? 03.07.2024 26:11

Join Drs Tania Jain and Pankit Vachhani as they discuss the nuance involved in the risk stratification of myelofibrosis and the latest research in prefibrotic myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999593. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast i...